Chapter 2 (The political economy of the right to health: a terrain
for contestation) introduces the concept of political economy as a
"terrain for contestation" where global markets and local
governments collide, and where inequalities between developed and
developing countries are deepened or, in some cases, challenged.
Building from the notion of political economy as a field of
contention, I discuss some of the coalitions formed by Big Pharma
and a diverse array of stakeholders - doctors, patients'
organizations, scientists - to resist the regulatory agendas of
governments aimed at making drugs more affordable and to reject the
challenges of competitors such as generic and biosimilar drugs
You are not authenticated to view the full text of this chapter or article.
Get access to the full article by using one of the access options below.